Curevac Nv Stock Market Value
| CVAC Stock | USD 2.77 0.11 4.14% |
| Symbol | CureVac |
CureVac NV Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CureVac NV. If investors know CureVac will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CureVac NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.49 | Revenue Per Share 0.294 | Quarterly Revenue Growth 0.905 | Return On Assets (0.25) | Return On Equity (0.54) |
The market value of CureVac NV is measured differently than its book value, which is the value of CureVac that is recorded on the company's balance sheet. Investors also form their own opinion of CureVac NV's value that differs from its market value or its book value, called intrinsic value, which is CureVac NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CureVac NV's market value can be influenced by many factors that don't directly affect CureVac NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CureVac NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if CureVac NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CureVac NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
CureVac NV 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CureVac NV's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CureVac NV.
| 10/26/2024 |
| 11/25/2024 |
If you would invest 0.00 in CureVac NV on October 26, 2024 and sell it all today you would earn a total of 0.00 from holding CureVac NV or generate 0.0% return on investment in CureVac NV over 30 days. CureVac NV is related to or competes with Merit Medical, SmartStop Self, Cadence Design, Microbot Medical, Asure Software, NetSol Technologies, and Q2 Holdings. CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based o... More
CureVac NV Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CureVac NV's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CureVac NV upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 16.27 | |||
| Value At Risk | (4.51) | |||
| Potential Upside | 4.45 |
CureVac NV Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CureVac NV's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CureVac NV's standard deviation. In reality, there are many statistical measures that can use CureVac NV historical prices to predict the future CureVac NV's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.38) | |||
| Total Risk Alpha | (0.73) | |||
| Treynor Ratio | (0.20) |
CureVac NV Backtested Returns
CureVac NV secures Sharpe Ratio (or Efficiency) of -0.0674, which signifies that the company had a -0.0674% return per unit of risk over the last 3 months. CureVac NV exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm CureVac NV's Risk Adjusted Performance of (0.05), mean deviation of 2.34, and Standard Deviation of 3.15 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.19, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, CureVac NV will likely underperform. At this point, CureVac NV has a negative expected return of -0.21%. Please make sure to confirm CureVac NV's maximum drawdown, kurtosis, day median price, as well as the relationship between the potential upside and daily balance of power , to decide if CureVac NV performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.01 |
Virtually no predictability
CureVac NV has virtually no predictability. Overlapping area represents the amount of predictability between CureVac NV time series from 26th of October 2024 to 10th of November 2024 and 10th of November 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CureVac NV price movement. The serial correlation of 0.01 indicates that just 1.0% of current CureVac NV price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.01 | |
| Spearman Rank Test | 0.02 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
CureVac NV lagged returns against current returns
Autocorrelation, which is CureVac NV stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting CureVac NV's stock expected returns. We can calculate the autocorrelation of CureVac NV returns to help us make a trade decision. For example, suppose you find that CureVac NV has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
CureVac NV regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If CureVac NV stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if CureVac NV stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in CureVac NV stock over time.
Current vs Lagged Prices |
| Timeline |
CureVac NV Lagged Returns
When evaluating CureVac NV's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of CureVac NV stock have on its future price. CureVac NV autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, CureVac NV autocorrelation shows the relationship between CureVac NV stock current value and its past values and can show if there is a momentum factor associated with investing in CureVac NV.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether CureVac NV offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CureVac NV's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Curevac Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Curevac Nv Stock:Check out CureVac NV Correlation, CureVac NV Volatility and CureVac NV Alpha and Beta module to complement your research on CureVac NV. For information on how to trade CureVac Stock refer to our How to Trade CureVac Stock guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
CureVac NV technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.